SPOREs : Organ-Specific SPORE Programs : Lung

[ SPOREs: Brain | Breast | GI | GU | GYN | Head and Neck | Leukemia | Lung | Lymphoma | Myeloma | Ovarian | Pancreatic | Prostate | Skin ]

Lung SPOREs

While the mortality rate has declined among most population groups over the past decade, cancers of the lung and bronchus are still the leading cause of cancer death among both males and females in the United States. According to estimates of the American Cancer Society, approximately 174,470 new cases of lung and bronchus cancer and 162,460 deaths were expected to be reported in the year 2006. The high mortality rate is due largely to the fact that a majority of these cancers are not detected until the disease has reached an advanced stage, when treatment is less effective. Because of the huge burden of lung cancer in terms of morbidity and mortality, lung cancer was an early focus of the SPORE Program. Three Lung SPOREs have been funded since 1992 and additional SPOREs were added raising the number to six in 2001. In the year 2003, the number of Lung Cancer SPOREs increased to seven.

To view the abstracts for the P50 SPOREs, please click on the name/address below.

The page is maintained by: Website Contact